Eradication of Established Tumors with Induction of Innate & Adaptive Immunological Memory in Multiple Preclinical Models with Systemically Administered Decoy Bacteria, a Multi-TLR Agonist Therapeutic Vaccine
Time: 11:30 am
day: Day Two
Details:
- Explore how attenuated and killed, non-pathogenic, Gram-negative (Decoy) bacteria can induce potent priming of innate and adaptive anti-tumor immunity
- See how Decoy bacteria can produce single agent activity and safe tumoreradicating synergy with each of several different classes of immuno-oncology agents
- Decoy bacteria can also produce safe, single agent activity against chronic viral infections, including HBV, in preclinical models
